PROVIDER PROFILE · NPI 1487651410

James Lax

GastroenterologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

119

Beneficiaries

—

Total drug cost

$14K

Distinct drugs

Brand share

17.6%

Top prescribed drugs

Famotidine70 claims

Omeprazole28 claims

Linaclotide21 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$207

Payment records

By payment type

Food and Beverage$207

REFERRAL NETWORK

Where James Lax's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 8 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ST LUKES ROOSEVELT HOSPITAL CENTER	47	115
Martin Baskin Internal Medicine · New York, NY	15	28
BETH ISRAEL MEDICAL CENTER	12	29

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MANHATTAN PHYSICIANS LABORATORIES LLC	110	473
East Side Endoscopy Llc Ambulatory Surgical Center · New York, NY	52	89
The New York And Presbyterian Hospital Opioid Treatment Program · New York, NY	47	141
ST LUKES ROOSEVELT HOSPITAL CENTER	34	58
Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ	25	46
Martin Baskin Internal Medicine · New York, NY	16	32
Kenneth Cordero Anesthesiology · New Hyde Park, NY	15	21
BETH ISRAEL MEDICAL CENTER	11	20

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history